INVIVO THERAPEUTICS HLDGS CO's ticker is NVIV and the CUSIP is 46186M209. A total of 64 filers reported holding INVIVO THERAPEUTICS HLDGS CO in Q1 2017. The put-call ratio across all filers is 0.70 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $8,000 | -75.8% | 14,124 | -66.7% | 0.00% | -50.0% |
| Q4 2017 | $33,000 | -54.2% | 42,424 | -14.4% | 0.00% | -60.0% |
| Q3 2017 | $72,000 | -45.9% | 49,549 | +0.8% | 0.01% | -50.0% |
| Q2 2017 | $133,000 | -46.8% | 49,175 | -20.3% | 0.01% | -47.4% |
| Q1 2017 | $250,000 | -19.9% | 61,675 | -16.9% | 0.02% | -24.0% |
| Q4 2016 | $312,000 | -38.1% | 74,175 | 0.0% | 0.02% | -39.0% |
| Q3 2016 | $504,000 | +17.5% | 74,175 | 0.0% | 0.04% | +17.1% |
| Q2 2016 | $429,000 | – | 74,175 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|